Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: Evaluation of the effect of leukocyte inclusion

The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet‐rich plasma (L‐PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte‐free (PRGF‐Endoret) and...

Full description

Saved in:
Bibliographic Details
Published inJournal of biomedical materials research. Part A Vol. 103; no. 3; pp. 1011 - 1020
Main Authors Anitua, E., Zalduendo, M. M., Prado, R., Alkhraisat, M. H., Orive, G.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.03.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet‐rich plasma (L‐PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte‐free (PRGF‐Endoret) and L‐PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte‐free fibrin matrices were homogenous while leukocyte‐containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)‐1β and IL‐16 but not in the platelet‐derived growth factors release (<1.5‐fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L‐PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF‐Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF‐Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011–1020, 2015.
AbstractList The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet-rich plasma (L-PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte-free (PRGF-Endoret) and L-PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte-free fibrin matrices were homogenous while leukocyte-containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)-1β and IL-16 but not in the platelet-derived growth factors release (&lt;1.5-fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L-PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF-Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF-Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines.
The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet‐rich plasma (L‐PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte‐free (PRGF‐Endoret) and L‐PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte‐free fibrin matrices were homogenous while leukocyte‐containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)‐1β and IL‐16 but not in the platelet‐derived growth factors release (<1.5‐fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L‐PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF‐Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF‐Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011–1020, 2015.
The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet-rich plasma (L-PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte-free (PRGF-Endoret) and L-PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte-free fibrin matrices were homogenous while leukocyte-containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)-1β and IL-16 but not in the platelet-derived growth factors release (<1.5-fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L-PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF-Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF-Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines.
The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet-rich plasma (L-PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte-free (PRGF-Endoret) and L-PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte-free fibrin matrices were homogenous while leukocyte-containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)-1 beta and IL-16 but not in the platelet-derived growth factors release (<1.5-fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L-PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF-Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF-Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. copyright 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011-1020, 2015.
Abstract The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet‐rich plasma (L‐PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte‐free (PRGF‐Endoret) and L‐PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte‐free fibrin matrices were homogenous while leukocyte‐containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)‐1β and IL‐16 but not in the platelet‐derived growth factors release (<1.5‐fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L‐PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF‐Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF‐Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011–1020, 2015.
The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting efficiency of leukocyte platelet-rich plasma (L-PRP) scaffolds in tissue regeneration. To assess this hypothesis, leukocyte-free (PRGF-Endoret) and L-PRP fibrin scaffolds were prepared, and both morphogen and proinflammatory cytokine release kinetics were analyzed. Clots were incubated with culture medium to monitor protein release over 8 days. Furthermore, the different fibrin scaffolds were morphologically characterized. Results show that leukocyte-free fibrin matrices were homogenous while leukocyte-containing ones were heterogeneous, loose and cellular. Leukocyte incorporation produced a significant increase in the contents of proinflammatory cytokines interleukin (IL)-1[beta] and IL-16 but not in the platelet-derived growth factors release (<1.5-fold). Surprisingly, the availability of vascular endothelial growth factor suffered an important decrease after 3 days of incubation in the case of L-PRP matrices. While the release of proinflammatory cytokines was almost absent or very low from PRGF-Endoret, the inclusion of leukocytes induced a major increase in these cytokines, which was characterized by the presence of a latent period. The PRGF-Endoret matrices were stable during the 8 days of incubation. The inclusion of leukocytes alters the growth factors release profile and also increased the dose of proinflammatory cytokines. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1011-1020, 2015.
Author Zalduendo, M. M.
Prado, R.
Alkhraisat, M. H.
Orive, G.
Anitua, E.
Author_xml – sequence: 1
  givenname: E.
  surname: Anitua
  fullname: Anitua, E.
  organization: Foundation Eduardo Anitua, Vitoria, Spain
– sequence: 2
  givenname: M. M.
  surname: Zalduendo
  fullname: Zalduendo, M. M.
  organization: Foundation Eduardo Anitua, Vitoria, Spain
– sequence: 3
  givenname: R.
  surname: Prado
  fullname: Prado, R.
  organization: Foundation Eduardo Anitua, Vitoria, Spain
– sequence: 4
  givenname: M. H.
  surname: Alkhraisat
  fullname: Alkhraisat, M. H.
  organization: Foundation Eduardo Anitua, Vitoria, Spain
– sequence: 5
  givenname: G.
  surname: Orive
  fullname: Orive, G.
  email: gorka.orive@ehu.es
  organization: Foundation Eduardo Anitua, Vitoria, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24890049$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1uEzEUhUeoiP7Aij2yxKYSmuC_cWx2bUkCqIWCQCwtx3NNnc7YwZ4B8gy8NA5pu2CBuvK90nc_-egcVnshBqiqpwRPCMb05WrZT8yENZTzB9UBaRpacyWave3MVc2oEvvVYc6rAgvc0EfVPuVSYczVQfX7Iqb1VfwGAZnQonWKPrjO9L0ZYtoguxnitQ-AEnRgMqDtMnibkUuxR5efFvN6FtqYYEDOL5MPKFvjXOza_ArNfphuNIOPAUWHhitA4BzYYbt1MF7Hogfkg-3GXKDH1UNnugxPbt6j6st89vnsTX3-YfH27OS8toJNeb0kuJXYNUIqw7DDrRFAiWkkGAuStkBoW2JKyZhtTCuIc9iQKTZqSSy3LTuqjnfekvb7CHnQvc8Wus4EiGPWRAgluRSc3gfFTEmm-D3Q0hBTjG3R5_-gqzimUDJrMi0ROWNqWqgXO8qmmHMCp9fJ9yZtNMF627wuzWuj_zZf6Gc3znHZQ3vH3lZdALoDfvoONv9z6XenFye31np35PMAv-6OTLrWovy00V_fL_Tl6cfXTC7mGrM_Uj7LEg
CitedBy_id crossref_primary_10_1080_09537104_2020_1856361
crossref_primary_10_1002_term_2079
crossref_primary_10_1088_1748_605X_aba086
crossref_primary_10_14202_vetworld_2023_799_810
crossref_primary_10_1186_s40729_019_0166_6
crossref_primary_10_3390_dj10090173
crossref_primary_10_3390_jcm12134512
crossref_primary_10_17116_hirurgia202105172
crossref_primary_10_1007_s00238_015_1116_z
crossref_primary_10_1007_s10792_017_0582_7
crossref_primary_10_1016_j_jaad_2019_04_037
crossref_primary_10_1080_09537104_2017_1319046
crossref_primary_10_3390_biom12071002
crossref_primary_10_1016_j_aanat_2017_12_006
crossref_primary_10_1016_j_jaad_2018_11_029
crossref_primary_10_4103_1673_5374_198973
crossref_primary_10_1002_cre2_26
crossref_primary_10_1007_s00238_015_1175_1
crossref_primary_10_3390_ijms25074069
crossref_primary_10_1016_j_repbio_2020_100472
crossref_primary_10_3390_jcm10235711
crossref_primary_10_5321_wjs_v4_i2_39
crossref_primary_10_1016_j_aanat_2021_151853
crossref_primary_10_1080_14712598_2021_1945030
crossref_primary_10_1007_s11420_016_9519_3
crossref_primary_10_2217_rme_2018_0087
crossref_primary_10_1016_j_ijpharm_2018_03_034
crossref_primary_10_1016_j_biomaterials_2021_121205
crossref_primary_10_3389_fphar_2021_606232
crossref_primary_10_1111_wrr_12886
crossref_primary_10_61872_sdj_2024_05_02
crossref_primary_10_1016_j_cveq_2023_06_007
crossref_primary_10_1055_s_0042_1755557
crossref_primary_10_1016_j_jtv_2021_02_011
crossref_primary_10_1038_s41427_021_00297_w
crossref_primary_10_1002_jbm_b_34234
crossref_primary_10_1016_j_cyto_2017_06_011
crossref_primary_10_3390_jcm7020013
crossref_primary_10_1016_j_jcyt_2020_02_006
crossref_primary_10_1007_s10856_017_6012_6
crossref_primary_10_1186_s40729_018_0140_8
crossref_primary_10_1111_jocd_12446
crossref_primary_10_25279_sak_541936
crossref_primary_10_1016_j_jos_2016_07_009
crossref_primary_10_1111_jocd_13212
crossref_primary_10_2147_JPR_S210715
crossref_primary_10_1097_DSS_0000000000001049
crossref_primary_10_1002_adhm_201801578
crossref_primary_10_1016_j_msec_2016_12_040
crossref_primary_10_1155_2015_542502
crossref_primary_10_1038_s41536_022_00239_2
crossref_primary_10_1155_2020_8546231
crossref_primary_10_1167_tvst_9_6_22
crossref_primary_10_3390_biomedicines10081991
crossref_primary_10_4274_cjms_2020_1736
crossref_primary_10_1155_2022_8767137
crossref_primary_10_36438_JOST2020007
crossref_primary_10_1517_14712598_2016_1157162
crossref_primary_10_1097_01_ASW_0000604168_62330_c7
crossref_primary_10_1111_clr_12742
crossref_primary_10_1080_14712598_2017_1259409
crossref_primary_10_3390_ijms21010139
crossref_primary_10_1007_s00167_017_4565_z
crossref_primary_10_1016_j_jor_2016_10_014
crossref_primary_10_1097_WON_0000000000000451
crossref_primary_10_3390_ijms22020824
crossref_primary_10_1007_s10856_024_06780_4
crossref_primary_10_1007_s40266_023_01040_6
crossref_primary_10_1016_j_tibtech_2020_07_011
crossref_primary_10_1016_j_biomaterials_2018_11_029
crossref_primary_10_1155_2015_179756
crossref_primary_10_1007_s40257_017_0277_x
crossref_primary_10_1088_1748_605X_aa8469
crossref_primary_10_1186_s12917_022_03491_2
crossref_primary_10_1097_MD_0000000000010242
crossref_primary_10_3390_app12147250
crossref_primary_10_1080_09537104_2017_1317731
crossref_primary_10_1097_01_ASW_0000464706_42760_fe
Cites_doi 10.2165/00007256-200939050-00002
10.1016/j.imbio.2007.09.012
10.1016/S0736-0266(01)00075-4
10.1016/S0736-0266(02)00141-9
10.1001/jama.2009.1986
10.1016/j.arthro.2012.05.011
10.1177/1947603511433181
10.1111/j.1582-4934.2009.00941.x
10.1053/j.oto.2012.01.004
10.1182/blood.V99.8.2997
10.1038/nrrheum.2010.4
10.1002/jlb.67.6.757
10.1302/0301-620X.89B3.18491
10.1007/s00167-012-2043-1
10.1177/0363546512442334
10.1053/j.oto.2011.11.001
10.1016/j.jconrel.2011.07.004
10.4049/jimmunol.176.11.6945
10.1177/03946320110241S215
10.1517/14712598.2012.632765
10.1160/TH09-03-0199
10.1016/S1357-2725(97)00053-8
10.1002/jbm.a.30585
10.1016/j.arthro.2009.08.019
10.1002/term.1721
10.1136/bjsm.2004.011312
10.1016/j.thromres.2007.06.016
10.1111/j.1365-2230.2011.04303.x
10.1177/0363546506294078
10.1146/annurev.immunol.16.1.137
10.1007/s00167-011-1837-x
10.1517/14712598.2011.554813
10.2106/JBJS.L.00019
10.1007/s11926-000-0021-y
10.4049/jimmunol.0803849
10.1016/j.transci.2012.06.017
10.1007/s00167-010-1207-0
10.1177/0363546511404877
10.1177/0363546511417792
10.1177/0363546506288850
10.2174/138920112800624382
10.1002/jor.20519
10.1016/S0016-5085(98)70642-0
10.1096/fasebj.11.1.9034166
10.1097/MBC.0b013e3283424911
10.1002/jor.20278
10.1007/s00402-010-1167-3
10.1016/j.aanat.2013.04.004
10.3109/17453670903350081
10.3899/jrheum.080346
ContentType Journal Article
Copyright 2014 Wiley Periodicals, Inc.
2015 Wiley Periodicals, Inc.
Copyright_xml – notice: 2014 Wiley Periodicals, Inc.
– notice: 2015 Wiley Periodicals, Inc.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QF
7QO
7QQ
7SC
7SE
7SP
7SR
7TA
7TB
7U5
8BQ
8FD
F28
FR3
H8D
H8G
JG9
JQ2
K9.
KR7
L7M
L~C
L~D
P64
7X8
7T5
H94
DOI 10.1002/jbm.a.35244
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Aluminium Industry Abstracts
Biotechnology Research Abstracts
Ceramic Abstracts
Computer and Information Systems Abstracts
Corrosion Abstracts
Electronics & Communications Abstracts
Engineered Materials Abstracts
Materials Business File
Mechanical & Transportation Engineering Abstracts
Solid State and Superconductivity Abstracts
METADEX
Technology Research Database
ANTE: Abstracts in New Technology & Engineering
Engineering Research Database
Aerospace Database
Copper Technical Reference Library
Materials Research Database
ProQuest Computer Science Collection
ProQuest Health & Medical Complete (Alumni)
Civil Engineering Abstracts
Advanced Technologies Database with Aerospace
Computer and Information Systems Abstracts – Academic
Computer and Information Systems Abstracts Professional
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Materials Research Database
Civil Engineering Abstracts
Aluminium Industry Abstracts
Technology Research Database
Computer and Information Systems Abstracts – Academic
Mechanical & Transportation Engineering Abstracts
Electronics & Communications Abstracts
ProQuest Computer Science Collection
Computer and Information Systems Abstracts
ProQuest Health & Medical Complete (Alumni)
Ceramic Abstracts
Materials Business File
METADEX
Biotechnology and BioEngineering Abstracts
Computer and Information Systems Abstracts Professional
Aerospace Database
Copper Technical Reference Library
Engineered Materials Abstracts
Biotechnology Research Abstracts
Solid State and Superconductivity Abstracts
Engineering Research Database
Corrosion Abstracts
Advanced Technologies Database with Aerospace
ANTE: Abstracts in New Technology & Engineering
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList MEDLINE - Academic

MEDLINE
AIDS and Cancer Research Abstracts
Materials Research Database
CrossRef
Materials Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1552-4965
EndPage 1020
ExternalDocumentID 3879792631
10_1002_jbm_a_35244
24890049
JBMA35244
ark_67375_WNG_PBQD38GF_0
Genre article
Journal Article
GroupedDBID ---
-~X
.3N
.DC
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
4.4
4ZD
50Z
51W
51X
52N
52O
52P
52S
52T
52W
52X
53G
5GY
5VS
66C
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACPRK
ACXBN
ACXQS
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
BAFTC
BDRZF
BFHJK
BROTX
BRXPI
BSCLL
BY8
CO8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
J0M
JPC
KQQ
LATKE
LAW
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O9-
OIG
P2P
P2W
P2X
P4D
PQQKQ
Q.N
QB0
QRW
R.K
RNS
ROL
RWI
RYL
SUPJJ
SV3
UB1
V2E
W8V
W99
WIH
WIK
WJL
WQJ
WRC
WXSBR
XG1
XV2
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QF
7QO
7QQ
7SC
7SE
7SP
7SR
7TA
7TB
7U5
8BQ
8FD
F28
FR3
H8D
H8G
JG9
JQ2
K9.
KR7
L7M
L~C
L~D
P64
7X8
7T5
H94
ID FETCH-LOGICAL-c6374-b10d80f5689a30f0da6e21a58eace82de12d0528833c5ad61ff0a170a9b1c4cd3
IEDL.DBID DR2
ISSN 1549-3296
IngestDate Fri Aug 16 01:03:49 EDT 2024
Fri Aug 16 21:11:14 EDT 2024
Fri Aug 16 13:18:33 EDT 2024
Mon Nov 04 11:33:49 EST 2024
Thu Sep 26 17:27:28 EDT 2024
Sat Sep 28 07:54:18 EDT 2024
Sat Aug 24 00:52:10 EDT 2024
Wed Oct 30 09:50:43 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords leukocytes
fibrin scaffold
growth factors
inflammation
platelet-rich plasma
Language English
License 2014 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6374-b10d80f5689a30f0da6e21a58eace82de12d0528833c5ad61ff0a170a9b1c4cd3
Notes ark:/67375/WNG-PBQD38GF-0
ArticleID:JBMA35244
istex:787FE7CE51885C64A7370BB504F1F924AADAA48E
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 24890049
PQID 1737443397
PQPubID 2034572
PageCount 10
ParticipantIDs proquest_miscellaneous_1669848642
proquest_miscellaneous_1660398394
proquest_miscellaneous_1652439334
proquest_journals_1737443397
crossref_primary_10_1002_jbm_a_35244
pubmed_primary_24890049
wiley_primary_10_1002_jbm_a_35244_JBMA35244
istex_primary_ark_67375_WNG_PBQD38GF_0
PublicationCentury 2000
PublicationDate March 2015
PublicationDateYYYYMMDD 2015-03-01
PublicationDate_xml – month: 03
  year: 2015
  text: March 2015
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Mount Laurel
PublicationTitle Journal of biomedical materials research. Part A
PublicationTitleAlternate J. Biomed. Mater. Res
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Sanchez M, Anitua E, Azofra J, Prado R, Muruzabal F, Andia I. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: Gross morphology and histology. Arthroscopy 2010;26:470-480.
Del Buono A, Papalia R, Denaro V, Maccauro G, Maffulli N. Platelet rich plasma and tendinopathy: State of the art. Int J Immunopathol Pharmacol 2011;24:79-83.
Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. A systems biology perspective on sVEGFR1: Its biological function, pathogenic role and therapeutic use. J Cell Mol Med 2010;14:528-552.
Lard LR, Roep BO, Toes RE, Huizinga TW. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis. J Rheumatol 2004;31:35-39.
Cruikshank WW, Kornfeld H, Center DM. Interleukin-16. J Leukoc Biol 2000;67:757-766.
Gersh KC, Nagaswami C, Weisel JW. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. Thromb Haemost 2009;102:1169-1175.
Archambault J, Tsuzaki M, Herzog W, Banes AJ. Stretch and interleukin-1beta induce matrix metalloproteinases in rabbit tendon cells in vitro. J Orthop Res 2002;20:36-39.
Perrin J, Morlon L, Vigneron C, Marchand-Arvier M. Influence of polymorphonuclear leukocytes on the plasma clot formation as evaluated by thromboelastometry (ROTEM). Thromb Res 2008;121:647-652.
Bochsen L, Johansson PI, Kristensen AT, Daugaard G, Ostrowski SR. The influence of platelets, plasma and red blood cells on functional haemostatic assays. Blood Coagul Fibrinolysis 2011;22:167-175.
Sanchez M, Anitua E, Orive G, Mujika I, Andia I. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med 2009;39:345-354.
Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, Castelein RM, Creemers LB, Dhert WJ. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 2008;26:404-410.
Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Krol W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br 2007;89:417-420.
Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF(R)-Endoret(R)) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol 2012;37:652-657.
Anitua E, Zalduendo MM, Alkhraisat M, Orive G. Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors. Ann Anat 2013;195:461-466.
Schuppan D, Schmid M, Somasundaram R, Ackermann R, Ruehl M, Nakamura T, Riecken EO. Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology 1998;114:139-152.
de Jonge S, de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: A double-blind randomized placebo-controlled trial. Am J Sports Med 2011;39:1623-1629.
Dragoo JL, Braun HJ, Durham JL, Ridley BA, Odegaard JI, Luong R, Arnoczky SP. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med 2012;40:1274-1281.
Blaschke S, Schulz H, Schwarz G, Blaschke V, Muller GA, Reuss-Borst M. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis. J Rheumatol 2001;28:12-21.
Anitua E, Sanchez M, Nurden AT, Zalduendo M, de la Fuente M, Orive G, Azofra J, Andia I. Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A 2006;77:285-293.
Horstmann WG, Slappendel R, van Hellemondt GG, Wymenga AW, Jack N, Everts PA. Autologous platelet gel in total knee arthroplasty: A prospective randomized study. Knee Surg Sports Traumatol Arthrosc 2011;19:115-121.
Filardo G, Kon E, Pereira Ruiz MT, Vaccaro F, Guitaldi R, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc 2012;20:2078-2087.
Grenier A, Chollet-Martin S, Crestani B, Delarche C, El Benna J, Boutten A, Andrieu V, Durand G, Gougerot-Pocidalo MA, Aubier M, Dehoux M. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. Blood 2002;99:2997-3004.
Center DM, Kornfeld H, Cruikshank WW. Interleukin-16. Int J Biochem Cell Biol 1997;29:1231-1234.
Anitua E, Sanchez M, Prado R, Orive G. The type of platelet-rich plasma may influence the safety of the approach. Knee Surg Sports Traumatol Arthrosc 2012. DOI: 10.1007/s00167-012-2043-1.
de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA 2010;303:144-149.
Anitua E, Prado R, Azkargorta M, Rodriguez-Suarez E, Iloro I, Casado-Vela J, Elortza F, Orive G. High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome. J Tissue Eng Regen Med 2013. DOI: 10.1002/term.1721.
Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 2011;39:2135-2140.
Bielecki T, Cieslik-Bielecka A, Żelawski M, Mikusek W. A side-effect induced by the combination of a demineralized freeze-dried bone allograft and leucocyte and platelet-rich plasma during treatment for large bone cysts: A 4-year follow-up clinical study. Transfus Apher Sci 2012;47:133-138.
Andia I, Sanchez M, Maffulli N. Joint pathology and platelet-rich plasma therapies. Expert Opin Biol Ther 2012;12:7-22.
Tsuzaki M, Guyton G, Garrett W, Archambault JM, Herzog W, Almekinders L, Bynum D, Yang X, Banes AJ. IL-1 beta induces COX2, MMP-1, −3 and −13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J Orthop Res 2003;21:256-264.
Andia I, Sanchez M, Maffulli N. Platelet rich plasma therapies for sports muscle injuries: Any evidence behind clinical practice? Expert Opin Biol Ther 2011;11:509-518.
Ohnishi T, Kakimoto K, Bandow K, Lowenstein CJ, Daikuhara Y, Matsuguchi T. Mature hepatocyte growth factor/scatter factor on the surface of human granulocytes is released by a mechanism involving activated factor Xa. J Immunol 2006;176:6945-6953.
Ludwiczek O, Kaser A, Koch RO, Vogel W, Cruikshank WW, Tilg H. Activation of caspase-3 by interferon alpha causes interleukin-16 secretion but fails to modulate activation induced cell death. Eur Cytokine Netw 2001;12:478-486.
Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release 2012;157:29-38.
Sanchez M, Anitua E, Azofra J, Andia I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007;35:245-251.
Anitua E, Prado R, Sánchez M, Orive G. Platelet-rich plasma: Preparation and formulation. Oper Tech Orthop 2012;22:25-32.
Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cusco X, Garcia-Balletbo M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg 2011;131:311-317.
Hamilton B, Knez W, Eirale C, Chalabi H. Platelet enriched plasma for acute muscle injury. Acta Orthop Belg 2010;76:443-448.
Peerbooms JC, de Wolf GS, Colaris JW, Bruijn DJ, Verhaar JA. No positive effect of autologous platelet gel after total knee arthroplasty. Acta Orthop 2009;80:557-562.
McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am 2012;94:e1431-1438.
Kisiday JD, McIlwraith CW, Rodkey WG, Frisbie DD, Steadman JR. Effects of platelet-rich plasma composition on anabolic and catabolic activities in equine cartilage and meniscal explants. Cartilage 2012;3:245-254.
Wasterlain AS, Braun HJ, Dragoo JL. Contents and formulations of platelet-rich plasma. Oper Tech Orthop 2012;22:33-42.
Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006;34:1774-1778.
Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. Faseb J 1997;11:51-59.
Helming L, Gordon S. The molecular basis of macrophage fusion. Immunobiology 2007;212:785-793.
Dohan Ehrenfest DM, Bielecki T, Jimbo R, Barbe G, Del Corso M, Inchingolo F, Sammartino G. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol 2012;13:1145-1152.
Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, Fortier LA. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2007;25:230-240.
Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 2010;6:232-241.
Scott A, Khan KM, Roberts CR, Cook JL, Duronio V. What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine. Br J Sports Med 2004;38:372-380.
Sanchez M, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, Albillos J, Garate R, Aguirre JJ, Padilla S, Orive G, Anitua E. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 2012;28:1070-1078.
Kishuku M, Nishioka Y, Abe S, Kishi J, Ogino H, Aono Y, Azuma M, Kinoshita K, Batmunkh R, Makino H, Sone S. Expression of soluble vascular endothelial growth factor receptor-1 in human monocyte-derived mature den
2010; 14
2006; 34
2009; 80
2010; 303
2006; 77
2002; 99
2011; 11
2006; 176
2008; 35
2000; 2
1998; 114
2012; 13
2012; 12
2011; 19
2007; 35
1998; 16
2007; 212
2004; 31
2010; 26
1997; 11
2004; 38
2008; 26
2011; 22
2011; 24
2013; 195
2012; 28
2001; 12
2012; 22
2007; 25
2012; 20
2010; 6
2010; 76
2012
2000; 67
1997; 29
2001; 28
2012; 37
2011; 39
2008; 121
2011; 131
2012; 94
2012; 3
2012; 157
2002; 20
2002; 23
2009; 102
2009; 183
2013
2012; 47
2007; 89
2003; 21
2009; 39
2012; 40
e_1_2_6_53_1
e_1_2_6_32_1
e_1_2_6_30_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_36_1
e_1_2_6_11_1
e_1_2_6_34_1
e_1_2_6_17_1
e_1_2_6_55_1
e_1_2_6_15_1
e_1_2_6_38_1
Lard LR (e_1_2_6_51_1) 2004; 31
e_1_2_6_43_1
e_1_2_6_20_1
e_1_2_6_41_1
e_1_2_6_9_1
e_1_2_6_5_1
Blaschke S (e_1_2_6_50_1) 2001; 28
e_1_2_6_7_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_22_1
e_1_2_6_28_1
e_1_2_6_45_1
e_1_2_6_26_1
e_1_2_6_47_1
e_1_2_6_52_1
e_1_2_6_54_1
e_1_2_6_10_1
e_1_2_6_31_1
Conti P (e_1_2_6_49_1) 2002; 23
e_1_2_6_14_1
e_1_2_6_35_1
e_1_2_6_33_1
e_1_2_6_18_1
e_1_2_6_39_1
e_1_2_6_56_1
e_1_2_6_16_1
e_1_2_6_37_1
e_1_2_6_42_1
e_1_2_6_21_1
Hamilton B (e_1_2_6_12_1) 2010; 76
e_1_2_6_40_1
e_1_2_6_8_1
e_1_2_6_4_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_23_1
Ludwiczek O (e_1_2_6_48_1) 2001; 12
e_1_2_6_2_1
e_1_2_6_29_1
e_1_2_6_44_1
e_1_2_6_27_1
e_1_2_6_46_1
References_xml – volume: 34
  start-page: 1774
  year: 2006
  end-page: 1778
  article-title: Treatment of chronic elbow tendinosis with buffered platelet‐rich plasma
  publication-title: Am J Sports Med
– volume: 22
  start-page: 167
  year: 2011
  end-page: 175
  article-title: The influence of platelets, plasma and red blood cells on functional haemostatic assays
  publication-title: Blood Coagul Fibrinolysis
– volume: 25
  start-page: 230
  year: 2007
  end-page: 240
  article-title: Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons
  publication-title: J Orthop Res
– volume: 37
  start-page: 652
  year: 2012
  end-page: 657
  article-title: Antibacterial effect of plasma rich in growth factors (PRGF(R)‐Endoret(R)) against and strains
  publication-title: Clin Exp Dermatol
– volume: 183
  start-page: 8176
  year: 2009
  end-page: 8185
  article-title: Expression of soluble vascular endothelial growth factor receptor‐1 in human monocyte‐derived mature dendritic cells contributes to their antiangiogenic property
  publication-title: J Immunol
– volume: 11
  start-page: 509
  year: 2011
  end-page: 518
  article-title: Platelet rich plasma therapies for sports muscle injuries: Any evidence behind clinical practice?
  publication-title: Expert Opin Biol Ther
– volume: 22
  start-page: 33
  year: 2012
  end-page: 42
  article-title: Contents and formulations of platelet‐rich plasma
  publication-title: Oper Tech Orthop
– year: 2012
  article-title: The type of platelet‐rich plasma may influence the safety of the approach
  publication-title: Knee Surg Sports Traumatol Arthrosc
– volume: 39
  start-page: 345
  year: 2009
  end-page: 354
  article-title: Platelet‐rich therapies in the treatment of orthopaedic sport injuries
  publication-title: Sports Med
– volume: 29
  start-page: 1231
  year: 1997
  end-page: 1234
  article-title: Interleukin‐16
  publication-title: Int J Biochem Cell Biol
– volume: 94
  start-page: e1431
  year: 2012
  end-page: 1438
  article-title: Optimization of leukocyte concentration in platelet‐rich plasma for the treatment of tendinopathy
  publication-title: J Bone Joint Surg Am
– volume: 6
  start-page: 232
  year: 2010
  end-page: 241
  article-title: IL‐1 pathways in inflammation and human diseases
  publication-title: Nat Rev Rheumatol
– volume: 24
  start-page: 79
  year: 2011
  end-page: 83
  article-title: Platelet rich plasma and tendinopathy: State of the art
  publication-title: Int J Immunopathol Pharmacol
– volume: 76
  start-page: 443
  year: 2010
  end-page: 448
  article-title: Platelet enriched plasma for acute muscle injury
  publication-title: Acta Orthop Belg
– volume: 121
  start-page: 647
  year: 2008
  end-page: 652
  article-title: Influence of polymorphonuclear leukocytes on the plasma clot formation as evaluated by thromboelastometry (ROTEM)
  publication-title: Thromb Res
– volume: 39
  start-page: 1623
  year: 2011
  end-page: 1629
  article-title: One‐year follow‐up of platelet‐rich plasma treatment in chronic Achilles tendinopathy: A double‐blind randomized placebo‐controlled trial
  publication-title: Am J Sports Med
– volume: 80
  start-page: 557
  year: 2009
  end-page: 562
  article-title: No positive effect of autologous platelet gel after total knee arthroplasty
  publication-title: Acta Orthop
– volume: 2
  start-page: 459
  year: 2000
  end-page: 465
  article-title: Osteoarthritis and cartilage: The role of cytokines
  publication-title: Curr Rheumatol Rep
– volume: 102
  start-page: 1169
  year: 2009
  end-page: 1175
  article-title: Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes
  publication-title: Thromb Haemost
– volume: 35
  start-page: 245
  year: 2007
  end-page: 251
  article-title: Comparison of surgically repaired Achilles tendon tears using platelet‐rich fibrin matrices
  publication-title: Am J Sports Med
– volume: 23
  start-page: 103
  year: 2002
  end-page: 108
  article-title: Interleukin‐16 network in inflammation and allergy
  publication-title: Allergy Asthma Proc
– volume: 77
  start-page: 285
  year: 2006
  end-page: 293
  article-title: Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities
  publication-title: J Biomed Mater Res A
– volume: 21
  start-page: 256
  year: 2003
  end-page: 264
  article-title: IL‐1 beta induces COX2, MMP‐1, −3 and −13, ADAMTS‐4, IL‐1 beta and IL‐6 in human tendon cells
  publication-title: J Orthop Res
– volume: 11
  start-page: 51
  year: 1997
  end-page: 59
  article-title: Growth factors in the extracellular matrix
  publication-title: Faseb J
– volume: 39
  start-page: 2135
  year: 2011
  end-page: 2140
  article-title: Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet‐rich plasma
  publication-title: Am J Sports Med
– volume: 38
  start-page: 372
  year: 2004
  end-page: 380
  article-title: What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine
  publication-title: Br J Sports Med
– volume: 26
  start-page: 470
  year: 2010
  end-page: 480
  article-title: Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: Gross morphology and histology
  publication-title: Arthroscopy
– volume: 47
  start-page: 133
  year: 2012
  end-page: 138
  article-title: A side‐effect induced by the combination of a demineralized freeze‐dried bone allograft and leucocyte and platelet‐rich plasma during treatment for large bone cysts: A 4‐year follow‐up clinical study
  publication-title: Transfus Apher Sci
– year: 2013
  article-title: High‐throughput proteomic characterization of plasma rich in growth factors (PRGF‐Endoret)‐derived fibrin clot interactome
  publication-title: J Tissue Eng Regen Med
– volume: 22
  start-page: 25
  year: 2012
  end-page: 32
  article-title: Platelet‐rich plasma: Preparation and formulation
  publication-title: Oper Tech Orthop
– volume: 31
  start-page: 35
  year: 2004
  end-page: 39
  article-title: Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis
  publication-title: J Rheumatol
– volume: 157
  start-page: 29
  year: 2012
  end-page: 38
  article-title: Perspectives and challenges in regenerative medicine using plasma rich in growth factors
  publication-title: J Control Release
– volume: 20
  start-page: 36
  year: 2002
  end-page: 39
  article-title: Stretch and interleukin‐1beta induce matrix metalloproteinases in rabbit tendon cells in vitro
  publication-title: J Orthop Res
– volume: 19
  start-page: 115
  year: 2011
  end-page: 121
  article-title: Autologous platelet gel in total knee arthroplasty: A prospective randomized study
  publication-title: Knee Surg Sports Traumatol Arthrosc
– volume: 3
  start-page: 245
  year: 2012
  end-page: 254
  article-title: Effects of platelet‐rich plasma composition on anabolic and catabolic activities in equine cartilage and meniscal explants
  publication-title: Cartilage
– volume: 40
  start-page: 1274
  year: 2012
  end-page: 1281
  article-title: Comparison of the acute inflammatory response of two commercial platelet‐rich plasma systems in healthy rabbit tendons
  publication-title: Am J Sports Med
– volume: 99
  start-page: 2997
  year: 2002
  end-page: 3004
  article-title: Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils
  publication-title: Blood
– volume: 28
  start-page: 1070
  year: 2012
  end-page: 1078
  article-title: A randomized clinical trial evaluating plasma rich in growth factors (PRGF‐Endoret) versus hyaluronic acid in the short‐term treatment of symptomatic knee osteoarthritis
  publication-title: Arthroscopy
– volume: 67
  start-page: 757
  year: 2000
  end-page: 766
  article-title: Interleukin‐16
  publication-title: J Leukoc Biol
– volume: 14
  start-page: 528
  year: 2010
  end-page: 552
  article-title: A systems biology perspective on sVEGFR1: Its biological function, pathogenic role and therapeutic use
  publication-title: J Cell Mol Med
– volume: 89
  start-page: 417
  year: 2007
  end-page: 420
  article-title: Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study
  publication-title: J Bone Joint Surg Br
– volume: 26
  start-page: 404
  year: 2008
  end-page: 410
  article-title: Antimicrobial activity of platelet–leukocyte gel against Staphylococcus aureus
  publication-title: J Orthop Res
– volume: 12
  start-page: 7
  year: 2012
  end-page: 22
  article-title: Joint pathology and platelet‐rich plasma therapies
  publication-title: Expert Opin Biol Ther
– volume: 114
  start-page: 139
  year: 1998
  end-page: 152
  article-title: Collagens in the liver extracellular matrix bind hepatocyte growth factor
  publication-title: Gastroenterology
– volume: 303
  start-page: 144
  year: 2010
  end-page: 149
  article-title: Platelet‐rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial
  publication-title: JAMA
– volume: 195
  start-page: 461
  year: 2013
  end-page: 466
  article-title: Release kinetics of platelet‐derived and plasma‐derived growth factors from autologous plasma rich in growth factors
  publication-title: Ann Anat
– volume: 28
  start-page: 12
  year: 2001
  end-page: 21
  article-title: Interleukin 16 expression in relation to disease activity in rheumatoid arthritis
  publication-title: J Rheumatol
– volume: 176
  start-page: 6945
  year: 2006
  end-page: 6953
  article-title: Mature hepatocyte growth factor/scatter factor on the surface of human granulocytes is released by a mechanism involving activated factor Xa
  publication-title: J Immunol
– volume: 13
  start-page: 1145
  year: 2012
  end-page: 1152
  article-title: Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence‐based answer comparing a pure platelet‐rich plasma (P‐PRP) gel and a leukocyte‐ and platelet‐rich fibrin (L‐PRF)
  publication-title: Curr Pharm Biotechnol
– volume: 212
  start-page: 785
  year: 2007
  end-page: 793
  article-title: The molecular basis of macrophage fusion
  publication-title: Immunobiology
– volume: 20
  start-page: 2078
  year: 2012
  end-page: 2087
  article-title: Platelet‐rich plasma intra‐articular injections for cartilage degeneration and osteoarthritis: Single‐ versus double‐spinning approach
  publication-title: Knee Surg Sports Traumatol Arthrosc
– volume: 35
  start-page: 2306
  year: 2008
  end-page: 2312
  article-title: The interleukin 1beta pathway in the pathogenesis of osteoarthritis
  publication-title: J Rheumatol
– volume: 12
  start-page: 478
  year: 2001
  end-page: 486
  article-title: Activation of caspase‐3 by interferon alpha causes interleukin‐16 secretion but fails to modulate activation induced cell death
  publication-title: Eur Cytokine Netw
– volume: 131
  start-page: 311
  year: 2011
  end-page: 317
  article-title: Infiltration of plasma rich in growth factors for osteoarthritis of the knee short‐term effects on function and quality of life
  publication-title: Arch Orthop Trauma Surg
– volume: 16
  start-page: 137
  year: 1998
  end-page: 161
  article-title: Regulation of immune responses by TGF‐beta
  publication-title: Annu Rev Immunol
– ident: e_1_2_6_14_1
  doi: 10.2165/00007256-200939050-00002
– ident: e_1_2_6_34_1
  doi: 10.1016/j.imbio.2007.09.012
– ident: e_1_2_6_43_1
  doi: 10.1016/S0736-0266(01)00075-4
– ident: e_1_2_6_44_1
  doi: 10.1016/S0736-0266(02)00141-9
– ident: e_1_2_6_21_1
  doi: 10.1001/jama.2009.1986
– ident: e_1_2_6_8_1
  doi: 10.1016/j.arthro.2012.05.011
– ident: e_1_2_6_26_1
  doi: 10.1177/1947603511433181
– ident: e_1_2_6_40_1
  doi: 10.1111/j.1582-4934.2009.00941.x
– ident: e_1_2_6_15_1
  doi: 10.1053/j.oto.2012.01.004
– ident: e_1_2_6_35_1
  doi: 10.1182/blood.V99.8.2997
– ident: e_1_2_6_41_1
  doi: 10.1038/nrrheum.2010.4
– ident: e_1_2_6_47_1
  doi: 10.1002/jlb.67.6.757
– ident: e_1_2_6_52_1
  doi: 10.1302/0301-620X.89B3.18491
– ident: e_1_2_6_55_1
  doi: 10.1007/s00167-012-2043-1
– ident: e_1_2_6_24_1
  doi: 10.1177/0363546512442334
– ident: e_1_2_6_56_1
  doi: 10.1053/j.oto.2011.11.001
– ident: e_1_2_6_13_1
  doi: 10.1016/j.jconrel.2011.07.004
– ident: e_1_2_6_38_1
  doi: 10.4049/jimmunol.176.11.6945
– ident: e_1_2_6_4_1
  doi: 10.1177/03946320110241S215
– ident: e_1_2_6_10_1
  doi: 10.1517/14712598.2012.632765
– ident: e_1_2_6_29_1
  doi: 10.1160/TH09-03-0199
– ident: e_1_2_6_46_1
  doi: 10.1016/S1357-2725(97)00053-8
– ident: e_1_2_6_31_1
  doi: 10.1002/jbm.a.30585
– ident: e_1_2_6_7_1
  doi: 10.1016/j.arthro.2009.08.019
– ident: e_1_2_6_3_1
  doi: 10.1002/term.1721
– volume: 76
  start-page: 443
  year: 2010
  ident: e_1_2_6_12_1
  article-title: Platelet enriched plasma for acute muscle injury
  publication-title: Acta Orthop Belg
  contributor:
    fullname: Hamilton B
– ident: e_1_2_6_18_1
  doi: 10.1136/bjsm.2004.011312
– ident: e_1_2_6_32_1
  doi: 10.1016/j.thromres.2007.06.016
– volume: 23
  start-page: 103
  year: 2002
  ident: e_1_2_6_49_1
  article-title: Interleukin‐16 network in inflammation and allergy
  publication-title: Allergy Asthma Proc
  contributor:
    fullname: Conti P
– ident: e_1_2_6_54_1
  doi: 10.1111/j.1365-2230.2011.04303.x
– ident: e_1_2_6_6_1
  doi: 10.1177/0363546506294078
– ident: e_1_2_6_33_1
  doi: 10.1146/annurev.immunol.16.1.137
– volume: 31
  start-page: 35
  year: 2004
  ident: e_1_2_6_51_1
  article-title: Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis
  publication-title: J Rheumatol
  contributor:
    fullname: Lard LR
– ident: e_1_2_6_25_1
  doi: 10.1007/s00167-011-1837-x
– ident: e_1_2_6_11_1
  doi: 10.1517/14712598.2011.554813
– volume: 12
  start-page: 478
  year: 2001
  ident: e_1_2_6_48_1
  article-title: Activation of caspase‐3 by interferon alpha causes interleukin‐16 secretion but fails to modulate activation induced cell death
  publication-title: Eur Cytokine Netw
  contributor:
    fullname: Ludwiczek O
– ident: e_1_2_6_16_1
  doi: 10.2106/JBJS.L.00019
– ident: e_1_2_6_45_1
  doi: 10.1007/s11926-000-0021-y
– ident: e_1_2_6_39_1
  doi: 10.4049/jimmunol.0803849
– ident: e_1_2_6_27_1
  doi: 10.1016/j.transci.2012.06.017
– ident: e_1_2_6_22_1
  doi: 10.1007/s00167-010-1207-0
– ident: e_1_2_6_20_1
  doi: 10.1177/0363546511404877
– ident: e_1_2_6_19_1
  doi: 10.1177/0363546511417792
– ident: e_1_2_6_5_1
  doi: 10.1177/0363546506288850
– ident: e_1_2_6_30_1
  doi: 10.2174/138920112800624382
– ident: e_1_2_6_53_1
  doi: 10.1002/jor.20519
– volume: 28
  start-page: 12
  year: 2001
  ident: e_1_2_6_50_1
  article-title: Interleukin 16 expression in relation to disease activity in rheumatoid arthritis
  publication-title: J Rheumatol
  contributor:
    fullname: Blaschke S
– ident: e_1_2_6_36_1
  doi: 10.1016/S0016-5085(98)70642-0
– ident: e_1_2_6_37_1
  doi: 10.1096/fasebj.11.1.9034166
– ident: e_1_2_6_28_1
  doi: 10.1097/MBC.0b013e3283424911
– ident: e_1_2_6_17_1
  doi: 10.1002/jor.20278
– ident: e_1_2_6_9_1
  doi: 10.1007/s00402-010-1167-3
– ident: e_1_2_6_2_1
  doi: 10.1016/j.aanat.2013.04.004
– ident: e_1_2_6_23_1
  doi: 10.3109/17453670903350081
– ident: e_1_2_6_42_1
  doi: 10.3899/jrheum.080346
SSID ssj0026052
Score 2.4728167
Snippet The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the conflicting...
The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet-rich plasma (PRP) may explain the conflicting...
Abstract The potential influence of leukocyte incorporation in the kinetic release of growth factors from platelet‐rich plasma (PRP) may explain the...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 1011
SubjectTerms Cell Adhesion
Culture
Cytokines
Cytokines - metabolism
Epidermal Growth Factor - metabolism
Fibrin
Fibrin - chemistry
fibrin scaffold
Growth factors
Hepatocyte Growth Factor - metabolism
Humans
Hydrogels - chemistry
Inclusions
Inflammation
Insulin - metabolism
Insulin-Like Growth Factor I - metabolism
Intercellular Signaling Peptides and Proteins - metabolism
Interleukin-16 - metabolism
Interleukin-1beta - metabolism
Leukocytes
Leukocytes - cytology
Monitors
Optics and Photonics
Platelet-Derived Growth Factor - metabolism
platelet-rich plasma
Platelet-Rich Plasma - metabolism
Scaffolds
Tissue Engineering - methods
Transforming Growth Factor beta1 - metabolism
Vascular Endothelial Growth Factor A - metabolism
Title Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: Evaluation of the effect of leukocyte inclusion
URI https://api.istex.fr/ark:/67375/WNG-PBQD38GF-0/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjbm.a.35244
https://www.ncbi.nlm.nih.gov/pubmed/24890049
https://www.proquest.com/docview/1737443397
https://search.proquest.com/docview/1652439334
https://search.proquest.com/docview/1660398394
https://search.proquest.com/docview/1669848642
Volume 103
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZQucCB9yNQkJEqLijbOLYTh1tLd7eqtFWpqOjNcmJHgt0mqEkk4MQfQOI38kuYcdLQIrQS3BJlovgxk_lsz3xDyFYKPiy2TILyOum3bkIlnQitM6Uz4AAZx9zhxWGyfyIOTuXpEJuDuTA9P8S44YaW4f_XaOAmb7Z_k4Z-zM8mZgL4QSAbKOMpBnTtHY_kUQjU_VknrIBCHmfJkJ0HT7YvvXvFH13Hof38N7B5Fbt65zO73VdYbTxnIcacLCddm0-Kr38wOv53v-6QWwMspTu9Ht0l11x1j9y8RFZ4n3xf1DAnNSgcNZWl0BZQTtCnM39OT4svbb0EaYpVWMA1UrxBDmiKGSz06Hg--_ntx7TCyiYtLTHToKJNYcqyXtnmNZ2OtOO0LinAUtqHmuDdynXLGj7g6IeqWHW4wfeAnMym797sh0Mxh7BIeCrCnEVWRaVMVGZ4VEbWJC5mRir48zsVW8diCxOGtY8LaWzCyjIyLI1MlrNCFJY_JBtVXbnHhAKiABSUS4Pk99BMI1Ll4lg5a1hZRHlAti6mVH_qOTt0z84caxhdbbQf3YC89NM9ypjzJYa5pVK_P5zro923e1zNZzoKyOaFPujBwhvNQFAIDtockBfjY7BNPHAxlas7kEngOzzjXKyTSSKeAUxdL5MpoWCpGJBHvT6OjY6FynCZF5BXXqvW9Vgf7C52_NWTf5J-Sm4ATpQYesfkJtlozzv3DLBYmz_3JvcLVlsxSQ
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagPQAH3o9AASNVXFC2cewkDreW7oPSXZWqVXuznNiRYLcJ6m4k4MQfQOI38kuYcbKhRWgluCXKRPFjJvN57PmGkM0EfFhoWATKayMXuvFlZIVvrC6sBgfIOOYOjyfx6FjsnUanbcANc2Eafogu4IaW4f7XaOAYkN76zRr6MTvr6R4ACCGuknUweI6lG3YPO_oohOputxPWQD4P07jNz4MnWxdevuSR1nFwP_8Nbl5Gr879DG4RtWx4c-pk2qsXWS__-gen4__37Da52SJTut2o0h1yxZZ3yY0LfIX3yPdxBdNSgc5RXRoKjQH9BJU6c1v1NP-yqKYgTbEQC3hHijdIA00xiYUeHA4HP7_96JdY3GRBC0w2KOk810VRzcz8Ne13zOO0KiggU9qcNsG7ma2nFXzA0g9lPqsxxnefHA_6R29GflvPwc9jngg_Y4GRQRHFMtU8KAKjYxsyHUn4-VsZGstCAzOG5Y_zSJuYFUWgWRLoNGO5yA1_QNbKqrSPCAVQAUAoizTy30MztUikDUNpjWZFHmQe2VzOqfrU0HaohqA5VDC6Sis3uh556ea7k9HnUzzplkTqZDJUBzvvd7kcDlTgkY2lQqjWyOeKgaAQHBTaIy-6x2CeuOeiS1vVIBPDd3jKuVglEwc8BaS6WiaVQsJq0SMPG4XsGh0KmeJKzyOvnFqt6rHa2xlvu6vH_yT9nFwbHY331f7bybsn5DrAxqg5ibdB1hbntX0K0GyRPXP29ws17TVc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaglRAceD8CBYxUcUHZJrGTONxautlS2NVSUdGb5cS2BLtNqm4iASf-ABK_kV_CjLMNLUIrwS1RJoofM5nP9sw3hGym4MMiHcagvCZ2Wze-iA33tVHWKHCAIcPc4fEk2Tvk-0fx0TI2B3NhOn6IfsMNLcP9r9HAT7Td-k0a-qk4HqgB4AfOL5N1ngD2RUx00LNHIVJ3h52wBPJZlCXL9Dx4snXu5QsOaR3H9vPf0OZF8Oq8T36jK7G6cKSFGHQyG7RNMSi__kHp-N8du0muL3Ep3e4U6Ra5ZKrb5No5tsI75Pu4hkmpQeOoqjSFtoB2gkIdu4N6Wn5p6hlIUyzDAr6R4g2SQFNMYaHTg1H-89uPYYWlTRpqMdWgootSWVvP9eIlHfa847S2FHAp7WJN8G5u2lkNHzD0Y1XOW9zhu0sO8-H7V3v-spqDXyYs5X4RBloENk5EplhgA60SE4UqFvDrNyLSJow0TBgWPy5jpZPQ2kCFaaCyIix5qdk9slbVlXlAKEAKgEFFrJD9HpqpeCpMFAmjVWjLoPDI5tmUypOOtEN29MyRhNGVSrrR9chzN929jDqdYZxbGssPk5Gc7rzbZWKUy8AjG2f6IJcmvpAhCHLOQJ098qx_DMaJJy6qMnULMgl8h2WM8VUyScAywKmrZTLBBawVPXK_08e-0REXGa7zPPLCadWqHsv9nfG2u3r4T9JPyZXpbi7fvp68eUSuAmaMuzC8DbLWnLbmMeCypnjirO8XdSQ0Cw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Morphogen+and+proinflammatory+cytokine+release+kinetics+from+PRGF%E2%80%90Endoret+fibrin+scaffolds%3A+Evaluation+of+the+effect+of+leukocyte+inclusion&rft.jtitle=Journal+of+biomedical+materials+research.+Part+A&rft.au=Anitua%2C+E.&rft.au=Zalduendo%2C+M.+M.&rft.au=Prado%2C+R.&rft.au=Alkhraisat%2C+M.+H.&rft.date=2015-03-01&rft.issn=1549-3296&rft.eissn=1552-4965&rft.volume=103&rft.issue=3&rft.spage=1011&rft.epage=1020&rft_id=info:doi/10.1002%2Fjbm.a.35244&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_jbm_a_35244
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-3296&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-3296&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-3296&client=summon